 Home > Active Ingredient News > Study of Nervous System > FDA approves new technology to relieve pain from osteoarthritis without medicine or surgery

FDA approves new technology to relieve pain from osteoarthritis without medicine or surgery

 Last Update: 2021-06-20
 Source: Internet
 Author: User

Tags

red treatment

lidocaine tooth pain

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 9, 2021, CyMedica Orthopedics announced that the US FDA has approved a regulatory application for its IntelliHab system to relieve knee osteoarthritis (knee osteoarthritis) pain

Symptomatic knee osteoarthritis, also known as degenerative joint disease, not only affects the health and mobility of tens of millions of patients, but related medical expenses may cause a huge social and economic burden in the future

The IntelliHab system relies on neuromuscular electrical stimulation therapy

▲IntelliHab system diagram (picture source: CyMedica Orthopedics official website)

The FDA's 501(K) approval is based on the positive results of a randomized, double-blind, multi-center clinical trial

Note: The original text has been deleted

Reference materials:

[1] CyMedica Orthopedics Announces FDA Clearance for IntelliHab™, a Novel Drug-free, Non-invasive Modality for Treatment of Knee Osteoarthritis Pain.

https:// osteoarthritis-pain-301308495.

[2] FDA clears CyMedica's app-connected muscle stimulation system to treat osteoarthritic knee pain.

▽ attention [drug Mingkang Germany ] micro-channel public number

[Medical attention Mingkang Germany ] ] micro-channel public number

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.